Nymox Pharmaceutical
NYMX
#10793
Rank
C$26.03 M
Marketcap
Country
C$0.29
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.93 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.31 Million, an increase over its 2021 earnings that were of -C$17.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.93 Million-68.62%
2022 -C$9.31 Million-47.71%
2021 -C$17.81 Million6.61%
2020 -C$16.71 Million-10.91%
2019 -C$18.75 Million24.24%
2018 -C$15.09 Million-20.03%
2017 -C$18.87 Million2.71%
2016 -C$18.37 Million-63.86%
2015 -C$50.83 Million674.44%
2014 -C$6.57 Million-6.11%
2013 -C$7 Million-35.66%
2012 -C$10.87 Million-20.76%
2011 -C$13.72 Million38.33%
2010 -C$9.92 Million35.59%
2009 -C$7.32 Million11.8%
2008 -C$6.54 Million-12.94%
2007 -C$7.52 Million8.85%
2006 -C$6.91 Million36.5%
2005 -C$5.06 Million-4.4%
2004 -C$5.29 Million-14.58%
2003 -C$6.2 Million
2001 -C$4.55 Million-20.54%
2000 -C$5.72 Million21.72%
1999 -C$4.7 Million-25.56%
1998 -C$6.31 Million101.3%
1997 -C$3.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.38 B-1,212,871.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.85 B-319,720.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.60 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.92 B-1,554,732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$2.00 B-65,069.92%๐Ÿ‡บ๐Ÿ‡ธ USA